drugset / Trial / NCT00564447

Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers

NCT00564447

Phase 4 Completed 48 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study is to evaluate the drug concentrations of AzaSite™ compared to Vigamox at various time points in conjunctiva tissue of healthy volunteers

Timeline

Start
2007-12
Primary completion
2007-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 1 % Topical
Subject Moxifloxacin Small molecule 0.5 % Topical